Lanean...
Tetrabenazine in treatment of hyperkinetic movement disorders: an observational study
BACKGROUND: Tetrabenazine (TBZ) is commonly used in hyperkinetic movement disorders. In this retrospective study, we aimed to assess the TBZ effectiveness and adverse events (AEs) in Huntington disease (HD), vascular chorea, tics, dystonia, tardive oromandibular (OM) dyskinesia and other tardive syn...
Gorde:
| Argitaratua izan da: | Ther Adv Neurol Disord |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5367646/ https://ncbi.nlm.nih.gov/pubmed/28382107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285616677004 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|